- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Non pharmacological intervention
- Convalescent plasma
Population: Adults
Individuals aged 18-64 years
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Paediatric
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- Elderly
- Fragile population
- Paediatric
- Immunocompromised host
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Antivirals
- Plitidepsin
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Elderly
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Antivirals
- Tecovirimat
- Adults
- General population
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- mRNA-1769
- Adults
- General population
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- MVA-BN